Treatment Landscape for Patients with HER2-Positive Metastatic Breast Cancer: A Review on Emerging Treatment Options

The prognosis of HER2-positive metastatic breast cancer (MBC) has radically changed in recent years and continues to improve due to the broad application of effective therapies like monoclonal antibodies and small molecules targeting HER2. Persistent dependency of tumor cells on the oncogene HER2, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gampenrieder, Simon Peter, Castagnaviz, Vanessa, Rinnerthaler, Gabriel, Greil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602897/
https://www.ncbi.nlm.nih.gov/pubmed/33149670
http://dx.doi.org/10.2147/CMAR.S235121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602897/
https://www.ncbi.nlm.nih.gov/pubmed/33149670
http://dx.doi.org/10.2147/CMAR.S235121

Ejemplares similares